This application note demonstrates that the Agilent 6475 triple quadrupole LC/MS system can confidently quantify nitrosamine impurities at the low concentration levels specified by regulatory requirements. This method can be used to quantify these impurities in different ARB drug products, with some changes in chromatographic conditions based on the elution pattern of the drug product.
Also access the infographic 'What Stops Pharma Labs From Reaching Their Full Potential?' — a global survey conducted by Agilent, who teamed up with Frost & Sullivan, that focuses on the challenges and pain points that labs deal with every day.
To download your copy of this application note and the infographic complete the form opposite.